One might think that as the understanding of science grows, it would be easier to create new prescription drugs. But in reality, that’s what can make it harder.
The attempt to make new effective medication quite often ends in failure. As PhRMA pointed out, just 12 percent of drugs entering clinical trials ever making it to patients. Not only that, thousands won’t even make it past the early discovery and pre-clinical testing stages.
As it was stated via PR Newswire:
Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]
How to turn analytics into actual policy outcomes.
Biology isn’t rocket science. It’s harder than rocket science. Each living thing is an amazingly complex system and each interacts with other living things in complex ways. That is why discovering and developing new treatment and cures is such a complex and risky undertaking. On average, it takes more than 10 years for just one medicine to make its way through the entire R&D process. And the average cost to develop just one medicine has risen to $2.6 billion.
The good news is, even though the odds aren’t great and it’s costly, people are still desperately trying to find treatment for diseases like Alzheimer’s and forms cancer, among so many others. There are currently more than 7,000 medicines in development around the world, according to PhRMA.
Many tenacious people keep the ball rolling, thankfully.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Photo: Flickr user reynermedia